Written question asked by Saqib Bhatti (Conservative) on Wednesday, 18 August 2021, in the House of Commons. It was due for an answer on Monday, 6 September 2021. It was answered by Nadhim Zahawi (Conservative) on Tuesday, 7 September 2021 on behalf of the Department of Health and Social Care.
Travel: Coronavirus
- Question
-
To ask the Secretary of State for Health and Social Care, what discussions his Department has had with its counterpart in Italy in respect of British tourists' entry to Italy whose covid-19 vaccine was manufactured at Serum Institute in India.
- Answer
-
The Serum Institute of India (SII) manufactures both Vaxzevria and Covishield vaccines and both branded vaccines are exactly the same COVID-19 AstraZeneca vaccine. All SII-made doses approved by the United Kingdom (UK) regulator, the Medicines and Healthcare Products Regulatory Agency (MHRA) and administered in the UK were branded as the ’COVID-19 vaccine AstraZeneca’ which is now known commercially as ‘Vaxzevria’.
The government continues to liaise with counterparts in Italy and we are seeking Italian confirmation that they will recognise all AstraZeneca doses administered in the UK. We will ensure that Foreign, Commonwealth and Development Office Travel Advice is kept up to date following any developments.
Secondary information
- Type
- Written question
- Reference
- 41357
- Session
- 2021-22
- Subjects
- British nationals abroad Travel Vaccination Italy Coronavirus Serum Institute of India
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2021-09-07 16:48:39 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2021-22/41357
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2021-22/41357
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2021-22/41357